Adaptable: The Aspirin Study
10 March, 2016

Adaptable: The Aspirin Study

ADAPTABLE is a clinical trial comparing the effectiveness of 81mg versus 325mg daily doses of aspirin to prevent heart attacks and strokes in individuals living with heart disease. Participating REACHnet sites are Ochsner Health System and Baylor Scott & White Health.

ADAPTABLE is a clinical trial comparing the effectiveness of 81mg versus 325mg daily doses of aspirin to prevent heart attacks and strokes in individuals living with heart disease. Participating REACHnet sites are Ochsner Health System and Baylor Scott & White Health.

Learn More